Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b83d3f58d827036920e41d015af1c955 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2002-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2005-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_667938cdfed99b70610707c33ff50c64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fde88e526893b0be63509658b7034abe |
publicationDate |
2005-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1444261-B1 |
titleOfInvention |
Immunogenic alk (anaplastic lymphoma kinase) peptides |
abstract |
There are disclosed immunogenic peptides from Anaplastic Lymphoma Kinase (ALK), methods in vivo or in vitro for activating ALK-specific CTLs and for stimulating an immune response against tumors, and pharmaceutical compositions containing ALK peptides for tumor immunotherapy. |
priorityDate |
2001-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |